Myriad Genetics Reports Fiscal First-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Myriad Genetics (MYGN) PT Raised to $26 at Morgan Stanley
November 8, 2017 8:43 AM ESTMorgan Stanley raised its price target on Myriad Genetics (NASDAQ: MYGN) to $26.00 (from $24.00) while maintaining a Underweight rating.
... More